Publicaciones en las que colabora con Myriam Cuadrado López (11)

2022

  1. Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model

    Molecular Oncology, Vol. 16, Núm. 19, pp. 3533-3553

  2. Nuclear Vav3 is required for polycomb repression complex-1 activity in B-cell lymphoblastic leukemogenesis

    Nature Communications, Vol. 13, Núm. 1

2021

  1. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis

    EMBO Journal, Vol. 40, Núm. 22

  2. Distinct roles of vav family members in adaptive and innate immune models of arthritis

    Biomedicines, Vol. 9, Núm. 6

  3. Loss of aryl hydrocarbon receptor favors k-rasg12d-driven non-small cell lung cancer

    Cancers, Vol. 13, Núm. 16

2020

  1. VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma

    Nature Communications, Vol. 11, Núm. 1

  2. Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor

    Oncogene, Vol. 39, Núm. 28, pp. 5098-5111

2019

  1. Vav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanisms

    Oncogene, Vol. 38, Núm. 2, pp. 209-227

  2. YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib

    American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899

2018

  1. An unexpected tumor suppressor role for VAV1a

    Molecular and Cellular Oncology, Vol. 5, Núm. 3

  2. Vav3-induced cytoskeletal dynamics contribute to heterotypic properties of endothelial barriers

    Journal of Cell Biology, Vol. 217, Núm. 8, pp. 2813-2830